INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2012
|
Total net assets |
£128.9m |
|
NAV per share |
232.0p |
|
Share price |
204.5p |
|
Total value of unquoted investments |
£20.6m |
|
Total number of portfolio companies |
70 |
|
Cash |
7% NAV |
|
Cash committed and reserved to unquoted investments |
(6)% NAV |
|
Portfolio companies with < 1 year of cash |
15.81% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen Celgene Alexion |
6.8 5.4 5.0 |
|
Aptiv |
3.6 |
|
Insulet |
3.0 |
|
Pharmaxis |
2.9 |
|
Gilead |
2.9 |
|
Onyx |
2.5 |
|
Teva Vertex |
2.3 2.3 |
|
|
----------- |
|
Total |
36.7 |
|
Geographical Allocation |
% |
|
United States & Canada |
79 |
|
Europe |
8 |
|
Australia Israel |
3 3 |
|
Cash |
7 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
77 |
|
Unquoted |
16 |
|
Cash |
7 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 SEPTEMBER 2012